• News
  • SAN DIEGO
  • Finance

AstraZeneca rejects $119 billion offer from Pfizer

The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the protracted and increasingly bitter takeover saga.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!